Dana-Farber Cancer Institute/Northeastern University Joint Program in Cancer Drug Development enables collaborative efforts to advance the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. The two institutions believe that projects that combine these approaches are likely to have rapid and high impact effects on cancer therapy.
More information can be found here.
Posted: July 25, 2018 by bencheriflab
Prof. Bencherif receives DFCI/NU joint program grant
Dana-Farber Cancer Institute/Northeastern University Joint Program in Cancer Drug Development enables collaborative efforts to advance the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. The two institutions believe that projects that combine these approaches are likely to have rapid and high impact effects on cancer therapy.
More information can be found here.
Category: Uncategorized